학술논문

The essential genome of Streptococcus agalactiae.
Document Type
Article
Source
BMC Genomics. 5/26/2016, Vol. 17, p1-12. 12p. 2 Diagrams, 1 Chart, 4 Graphs.
Subject
*STREPTOCOCCUS agalactiae
*SEPSIS
*NEONATAL diseases
*STREPTOCOCCUS pyogenes
*GENOMICS
*GENETICS
Language
ISSN
1471-2164
Abstract
Background: Next-generation sequencing of transposon-genome junctions from a saturated bacterial mutant library (Tn-seq) is a powerful tool that permits genome-wide determination of the contribution of genes to fitness of the organism under a wide range of experimental conditions. We report development, testing, and results from a Tn-seq system for use in Streptococcus agalactiae (group B Streptococcus; GBS), an important cause of neonatal sepsis. Methods: Our method uses a Himar1 mini-transposon that inserts at genomic TA dinucleotide sites, delivered to GBS on a temperature-sensitive plasmid that is subsequently cured from the bacterial population. In order to establish the GBS essential genome, we performed Tn-seq on DNA collected from three independent mutant libraries--with at least 135,000 mutants per library--at serial 24 h time points after outgrowth in rich media. Results: After statistical analysis of transposon insertion density and distribution, we identified 13.5 % of genes as essential and 1.2 % as critical, with high levels of reproducibility. Essential and critical genes are enriched for fundamental cellular housekeeping functions, such as acyl-tRNA biosynthesis, nucleotide metabolism, and glycolysis. We further validated our system by comparing fitness assignments of homologous genes in GBS and a close bacterial relative, Streptococcus pyogenes, which demonstrated 93 % concordance. Finally, we used our fitness assignments to identify signal transduction pathway components predicted to be essential or critical in GBS. Conclusions: We believe that our baseline fitness assignments will be a valuable tool for GBS researchers and that our system has the potential to reveal key pathogenesis gene networks and potential therapeutic/preventative targets. [ABSTRACT FROM AUTHOR]